Results 201 to 210 of about 11,499 (250)

Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial. [PDF]

Front Endocrinol (Lausanne)
Yang X, Zhang X, Sun C, Zhao C, Kong X, Zhao M, Ji L, Li Y.   +7 more
europepmc   +1 more source

Reduced Weight Gain with Pioglitazone vs Vildagliptin in <i>CREBRF</i> rs373863828 A-allele Carriers: Insights from the WORTH Trial. [PDF]

Diabetes Metab Syndr Obes
Toomata ZLL, Jiang Y, Yeu RQ, Brandon R, Tweedie-Cullen RY, Nehren N, Doherty G, Watson H, Macaskill-Smith KA, Leask M, Merriman TR, Paul R, Merry TL, Shepherd PR, Murphy R.   +14 more
europepmc   +1 more source

HPLC and HPTLC methods for simultaneous quantification of Metformin hydrochloride, Vildagliptin and Dapagliflozin propanediol with comparative evaluation by greenness and whiteness assessment tools

Krinal Barot, Vaishali Thakkar, Devang Tandel, Gopi Patel, Rajesh Parmar, Kalpana Patel   +5 more
openalex   +1 more source

Henoch-Schönlein purpura induced by sitagliptin: A case report. [PDF]

SAGE Open Med Case Rep
Moschella A, Kirshen C.
europepmc   +1 more source

To Development and Validation Spectrophotometric Estimation of Vildagliptin Through Oxidative Coupling Reaction Using MBTH Reagent in Pharmaceutical Dosage Form

, 2020
Vaishali Patel, Divya Desai, Prachi Parmar, Krishna A. Bhatt, Rakshita S. Patel, Mrunali M. Shah, Dharti M. Patil   +6 more
openalex   +1 more source

Bullous pemphigoid associated with vildagliptin in an elderly adult with diabetes mellitus. First case in Peru. [PDF]

Rev Peru Med Exp Salud Publica
Concepción-Zavaleta M, Armas CD, Quiroz-Aldave JE, Ángeles-Zavaleta J, Durand-Vásquez MDC, Paz-Ibarra J, Quispe-Meza JY, Concepción-Urteaga L.   +7 more
europepmc   +1 more source

Gliptin-Induced Bullous Pemphigoid: Are Statins and Angiotensin Receptor Blockers the Cause? [PDF]

Dermatol Ther (Heidelb)
Beksac B, Temirkaynak MK, Gharehdaghi S, Atesci E, Kubat G, Erdem O, Ilter N, Adisen E.   +7 more
europepmc   +1 more source

Enhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes. [PDF]

BMJ Open Diabetes Res Care
Ryan DK, Keogh RH, Williamson E, Lumbers RT, Diaz-Ordaz K, Shah AD, Bidulka P.   +6 more
europepmc   +1 more source

Eco-Friendly electrochemical sensor for vildagliptin detection in human plasma: green approach using ZnO nanoparticles and graphene oxide. [PDF]

BMC Chem
Samy B, Mabrouk MM, Hamid MAA, Ahmed HM.
europepmc   +1 more source

Comparative Effect of SGLT2 Inhibitors and GLP-1 Agonists on Glycemic Control in Type 2 Diabetes Mellitus.

J Pharm Bioallied Sci
Prakash V, Gupta S, Singh S, Rawat A, Deshpande AV, Podder A, Jani P.   +6 more
europepmc   +1 more source